The Department of Biomedicine (DBM), a joint venture of the University of Basel and the University Hospitals Basel, brings together basic and clinical scientists to advance the understanding of health and disease. With more than 67 research groups and over 800 employees across six locations in Basel, the DBM offers a collaborative and international environment that fosters innovation, excellence, and impactful research. The Clinical Neuroimmunology group, led by Prof. Tobias Derfuss, is offering a fully funded postdoctoral position focused on autoimmune diseases affecting the nervous system, particularly multiple sclerosis and myasthenia gravis. The Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), headed by Professor Ludwig Kappos, is a non-profit foundation advancing research in multiple sclerosis and related neuroimmune disorders.
Fully funded postdoctoral position in a collaborative and international research environment.
Dieses Unternehmensprofil wurde automatisch erstellt. Wenn du für Universität Basel arbeitest, kannst du das Profil jetzt beanspruchen und verifizieren – kostenlos und in wenigen Minuten.
The Clinical Neuroimmunology group is led by Prof. Tobias Derfuss and collaborates closely with the Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), headed by Professor Ludwig Kappos.